Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed

INTRODUCTION: Several new active substances (ASs) targeting neuroblastoma (NBL) are under study. We aim to describe the developmental and regulatory status of a sample of ASs targeting NBL to underline the existing regulatory gaps in product development and to discuss possible improvements. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceci, Adriana, Conte, Rosa, Didio, Antonella, Landi, Annalisa, Ruggieri, Lucia, Giannuzzi, Viviana, Bonifazi, Fedele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377668/
https://www.ncbi.nlm.nih.gov/pubmed/37521350
http://dx.doi.org/10.3389/fmed.2023.1113460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377668/
https://www.ncbi.nlm.nih.gov/pubmed/37521350
http://dx.doi.org/10.3389/fmed.2023.1113460

Ejemplares similares